Mendaera has shown Focalist to five specialty audiences this year (urology at AUA and SUFU, regional anesthesia at ASRA, transplant at ATC, emergency medicine at ACEP), and its marketing and commercial teams are growing for the launch. But mendaera.com has just three product pages and no page for any specialty or procedure. What an anesthesiologist or an ER physician would need (their procedures, their study results, their workflow) is spread across event recaps that end in the same generic demo form. XACT Robotics, by contrast, has Procedures, Anatomies and Clinical Applications sections.
First action
Draft the regional anesthesia page from the ASRA recap and the study's pain-management results.
How to measure it
Specialty-page demo requests
- Now
- –
- Target
- 40 a quarter
- By
- 1 quarter
Steps
Pick the four
Specialties with clinical use and data today.
Chief Commercial Officer 1 day
Gather proof
Study results, posters and quotes per specialty.
VP Regulatory, Clinical and Quality Assurance 1 week
Write pages
Procedures, workflow, training, probes.
Director of Marketing 1 week
Regulatory review
Claims against the indications for use.
VP Regulatory, Clinical and Quality Assurance 1 week
Add routed form
Specialty field and rep routing.
Engineering Manager, Web Platform and Infrastructure 2 days
Link everywhere
Navigation, event pages, follow-up emails.
Director of Marketing 1 day
Measure
Visits and demo requests per page.
Director of Marketing monthly
Why it works
Build four specialty pages from material Mendaera already has: Urology (PCNL access, sacral neuromodulation), Regional anesthesia (nerve blocks), Nephrology and transplant (kidney biopsies) and Emergency medicine (thoracentesis, paracentesis, vascular access). Each page gets: the procedures in plain words, the relevant results from the 61-procedure study and the phantom study, a short physician video, the compatible probes, what training takes (one 45-minute session in the study), and a demo form that asks for the specialty and routes to the right rep. Link them from the navigation, the event pages and every conference follow-up email.
Physicians search and evaluate by procedure, not by device category. A page that speaks one specialty's language turns booth interest and search traffic into evaluation requests, and gives the sales team a link to send after every call.
Ready to use
ChecklistSpecialty page outline
[ ] Procedures covered, in the specialty's own words [ ] Results from the published study for this specialty [ ] Phantom-study chart: novice vs expert [ ] 60-90 second physician video [ ] Compatible probes (linear, phased array, Butterfly) [ ] Training: what the first case looks like [ ] Demo form with specialty field, routed to the right rep [ ] Indications for use and regulatory sign-off
Risks and how to handle them
Promotional claims outside the cleared indications
Every page goes through regulatory review against the indications for use before publishing.
Thin pages for newer specialties
Launch with the specialties that have published data and add others as data arrives.
Evidence
- Your websiteEvent pages show Focalist across specialties: AUA 2026 (PCNL and sacral neuromodulation, plus "the inaugural FOCUS meeting" of users), SUFU 2026 (sacral access for neuromodulation), ASRA 2026 (first nerve-block procedures, "all completed successfully on the first attempt"), ATC 2026 (kidney transplant biopsies) and ACEP 2026 (thoracentesis, paracentesis, regional nerve blocks and vascular access in emergency medicine). Every event page ends with the same generic "Sign Up for a Demo" form and shows "September 10-13, 2025" above its real date.Source
- Your websiteSitemap (59 URLs, checked November 4, 2026): home, technology, about, careers, contact, resources, indications for use, news, one FOCUS users' briefing, 35 press and news items and 13 event pages. There is no page for any specialty or procedure, no publications page, no clinician or patient resources and no blog; the same news appears several times (three items each for the FDA clearance, the $73M Series B and the Chief Commercial Officer hire).Source
- Your websiteAugust 12, 2026: a prospective multispecialty study in the World Journal of Urology reported technical success in "60 of 61" ultrasound-guided procedures "with zero device-related adverse events", across organ access, pain management and vascular access, by 11 physicians in urology, nephrology and anesthesiology, "after a single 45-minute training session".Source
- Your websiteTechnology page: three feature groups (Handheld Robotics, Guidance Software, Imaging Platform with "LINEAR, PHASED ARRAY AND Ultrasound-on-Chip" probes), repeated "Book a demo" buttons, and one study chart: a phantom-model comparison of 360 needle insertions (180 freehand, 180 robot) by novice, intermediate and expert users, labelled "Data on file", with a chart label spelled "Most Succesfull". Findings: higher accuracy than freehand "across every experience level" and it "closed the performance gap between novice and expert operators".Source
- Competitor researchRivals' own sites: XACT Robotics ("Changing Interventional Procedures. For Good.", the XACT ACE robotic system) has Clinical Applications, Anatomies, Procedures, Case Studies, Clinician Resources and Patient Resources sections; Clear Guide Medical sells AR- and AI-guided needle placement (SCENERGY TP) with a Publications page and a Mayo Clinic study; CIVCO sells ultrasound needle guides and transperineal prostate solutions.Source
- HiringProduction ramp: a Senior Manufacturing Technician "helping to scale our production capabilities and assemble the devices that will be shipped to our customers"; a Staff Manufacturing Engineer who will own contract manufacturers and lead "pilot builds", "production readiness reviews, and manufacturing ramp activities"; and an Incoming & Manufacturing Quality Technician (posted October 9, 2026).Source